Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML
- 14 July 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (3), 243-250
- https://doi.org/10.1038/sj.bmt.1704135
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantationBone Marrow Transplantation, 2002
- The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCyBone Marrow Transplantation, 2000
- Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulinBritish Journal of Haematology, 2000
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 1997
- European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matchingBone Marrow Transplantation, 1997
- Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated DonorsNew England Journal of Medicine, 1990
- Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effectBritish Journal of Haematology, 1988
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986
- ANTITHYMOCYTE SERUM AND METHOTREXATE FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGSTransplantation, 1973